ASHLEE BRATTIN: Open Payments
NPI 1518695980 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 68 payments from 29 companies in 2025. Trend: 2023 $53 · 2024 $810 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $152 |
| Novo Nordisk Inc | 6 | $124 |
| SHIELD THERAPEUTICS INC | 2 | $111 |
| Lilly USA, LLC | 6 | $106 |
| Dexcom, Inc. | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| PFIZER INC. | 3 | $65 |
| Lundbeck LLC | 2 | $58 |
Products named: REXULTI, ACCRUFER, Dexcom G6 Transmitter, FANAPT, Ozempic, CAPLYTA, MOUNJARO, Tymlos.
Industry payments across MO — which companies pay providers there.
